Laurent Fraisse

Laurent Fraisse is an experienced biotechnology and pharmaceutical executive and a leading expert in infectious diseases, having overseen R&D for large pharmaceutical firms such as Sanofi and Evotec. He also served as chair of the European Federation of Pharmaceutical Industries and Associations (EFPIA) Strategic Governing Group dedicated to infectious diseases.

In October 2019, Laurent joined the Drugs for Neglected Diseases initative (DNDi) as R&D director and executive team member. In this capacity, he drives DNDi’s science strategy and oversees all worldwide research and clinical activities. Laurent joined Sanofi in 1999 after a ten-year tenure as a science leader at Elf Atochem. During his 20 years at Sanofi, he rose to serve as vice president for infectious diseases R&D, addressing medical needs in bacterial, parasitic and viral related infections. He then joined Evotec as executive vice president for infectious diseases with a mission to accelerate the development of the infectious diseases research pipeline and initiate new open innovation R&D initiatives.

Laurent graduated from the Ecole Nationale Supérieure d’Agronomie in Rennes, France, with a specialty in biochemistry, and holds a Ph.D. in biotechnology from the Institut National Polytechnique in Toulouse, France